3-D Matrix Ltd DMTRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.50
- Day Range
- $2.50–2.50
- 52-Week Range
- $1.50–3.96
- Bid/Ask
- $0.01 / $402.75
- Shares Outstanding
- 127.98M
- Market Cap
- $300.53M
- Volume/Avg
- 200 / 13,205
Key Statistics
- Price/Earnings (Normalized)
- 17.30
- Price/Sales
- 4.53
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Additionally, the company develops ready-to-use hemostatic gels, mucosal elevation agents, and sealants to manage bleeding during complex procedures in gastroenterology, cardiac surgery, ENT, and urology. Its product portfolio includes PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 114
- Website
- https://www.3d-matrix.co.jp
Valuation
|
Metric
|
DMTRF
|
|---|---|
Price/Earnings (Normalized) | 17.30 |
Price/Book Value | 7.54 |
Price/Sales | 4.53 |
Price/Cash Flow | 48.77 |
Price/Earnings
DMTRF
Financial Strength
|
Metric
|
DMTRF
|
|---|---|
Quick Ratio | 1.87 |
Current Ratio | 3.11 |
Interest Coverage | 231.36 |
Quick Ratio
DMTRF
Profitability
|
Metric
|
DMTRF
|
|---|---|
Return on Assets (Normalized) | 51.56% |
Return on Equity (Normalized) | 91.88% |
Return on Invested Capital (Normalized) | 66.72% |
Return on Assets
DMTRF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|&hXn!$ | LOCK|>LXH! | $193B | |||
| Stryker Corp
SYK
| LOCK|$<%!Q^H | LOCK|$!% | $130B | |||
| Medtronic PLC
MDT
| LOCK|GsYZb& | LOCK|!s!Y | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|n>JRw# | LOCK|@&%&l | $75B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#MKnyY? | LOCK|Th>?! | $53B | |||
| DexCom Inc
DXCM
| LOCK|$d%rBLZ% | LOCK|Wwnh! | $34B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|d>&>FJS | LOCK|Bz | $33B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|#gF | LOCK|cR | $27B | |||
| Steris PLC
STE
| LOCK|pZz^Sq | LOCK|?RJ? | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|&FW^jcg | LOCK|!gJ | $19B |
United States